Picture: SUPPLIED
Picture: SUPPLIED

Buenos Aires — A world without enough food is just around the corner and can only be averted if humans forget their qualms about eating genetically modified (GM) crops, also known as biotech foods.

That’s according to Federico Trucco, CEO of Bioceres Crop Solutions, a company that’s literally trying to put bread on the table with the sometimes controversial technology.

Bioceres is trying to succeed where no other company has before by selling genetically modified wheat. While the vast majority of the world’s soybean and corn crops are already GM organisms (GMOs), these are fed to livestock. Biotech wheat, on the other hand, would be directly eaten by humans in bread and pasta, something consumers and regulators have roundly rejected in the past.

Now, only Argentina, where Bioceres is based, has ever approved a GM wheat.

Trucco’s Malthusian warning about future food shortages comes as world leaders meet to recommit to emissions goals at time when climate change is decimating harvests, and a surge in food prices is forcing more people to go hungry.

A new generation of drought-resistant GM crops would help put a floor under prices and mitigate the volatility of recent months

“It’s going to get to a point when it becomes exponential and all of a sudden we need to change things yesterday,” Trucco said in an interview. “And I feel that’s coming up fairly soon. We’re not talking beyond five years.”

Other companies, including Monsanto, before its merger with Bayer, have reversed course on GM wheat because of strong backlash, and Bioceres is still swimming against a tide of hesitant regulators and scared consumers.

Nevertheless, a milestone may come in just a matter of weeks with regulators in Brazil, a major importer, set to meet in May. If Brazil approves Bioceres’s wheat, the company would be able to start selling into its first market.

Trucco, a descendant of immigrant Italian farmers with a crop science doctorate from the University of Illinois, has described the task of getting GM wheat accepted as “monumental”.

For nearly two decades Bioceres — listed in New York and headquartered in Rosario, a river city that’s Argentina’s crop export hub — has been developing both GM wheat and soybeans to resist the droughts that are becoming more frequent from the Americas to Australasia. It’s also investing in a company that inserts animal genes into plants to increase protein content, a bet on the growing market for substitute meats.

A new generation of drought-resistant GM crops would help put a floor under prices and mitigate the volatility of recent months, Trucco said.

Bioceres is already in talks to convince millers and food manufacturers in Brazil to use its GM wheat strain as it also seeks clearance in other parts of the world, including the US, drought-racked Australia and Asia.

“If we can consolidate our position in Latin America then persuade other geographies with their customers to join the monumental quest, we can have a staged approach to making this a reality,” Trucco said.

Sustainable bond

Bioceres is preparing to sell up to $200m in sustainability-linked bonds that would pay coupons tied to carbon capture on farms. Because Bioceres’s crops continue to photosynthesise in drier weather, they theoretically take in 6% to 7% more carbon dioxide than other plants.

“We’ve had a very good reception” from investors, Trucco said. “There is interest in trying to understand how GMOs can help in the face of climate change.”

Other highlights from the interview:

  • The bond’s carbon capture goals start with 35,000 tonnes of CO2 by 2023 and an accumulated 156,000 tonnes in 2025. If Bioceres doesn’t meet the targets, the coupon rate would increase.

  • Trucco is expecting key Chinese approval for Bioceres’s drought-tolerant soybean seeds in the second half of 2021, depending on results from field trials. Without clearance, the company would have to delay plans to roll out production in Argentina.

  • Bioceres also needs to tweak the genetics of its soy technology for its next target markets of the northern US and southern Canada.

  • Speaking about Moolec, the alternative protein company in which Bioceres recently acquired a minority stake, Trucco said: “It’s not something we can pursue internally, because there are only so many fights we can fight.”

Bloomberg News. For more articles like this, please visit us at Bloomberg.com

Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.